Investment in Viatical Deal Leads to Lawsuit Lifespans Last Longer Than Expected
A dispute over an investment in viaticals will be litigated in New York, rather than California, a federal court decided last week. And in deciding to transfer the matter to the federal court for the Southern District of New York, the court in Amberger v. Legacy Capital Corp., Case No. 16-cv-05622-JSC, 2017 U.S. Dist. LEXIS 8392 (N.D. Calif. Jan. 20, 2017), also shed some light on what happens when an investment in viaticals goes bad – due to the fact that…